Clinical trial
IL-4 & Insulin Resistance in Patients With Atopic Dermatitis
NCT05372003 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IL-4 & Insulin Resistance in Patients With Atopic Dermatitis
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 9, 2022
- Completion date
- February 23, 2024
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis